Evidence map›Paper›PMID 39188262›Full record

ArticleActa naturae

Evaluation of HER2/neu Expression in Metastatic Axillary Lymph Node Tissue of Breast Cancer Patients Using [99mTc]Tc-(HE)3-G3.

O D Bragina, L A Tashireva, D M Loos, S V Vtorushin, A A Shulga, E N Konovalova, M E Borodina, V I Chernov, V M Tolmachev, S M Deyev

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta naturae. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

O D BraginaTomsk Cancer Research Institute, Tomsk, 634009 Russian Federation.
L A TashirevaTomsk Cancer Research Institute, Tomsk, 634009 Russian Federation.
D M LoosTomsk Cancer Research Institute, Tomsk, 634009 Russian Federation.
S V VtorushinTomsk Cancer Research Institute, Tomsk, 634009 Russian Federation.
A A ShulgaNational Research Tomsk Polytechnic University, Tomsk, 634050 Russian Federation.
E N KonovalovaNational Research Tomsk Polytechnic University, Tomsk, 634050 Russian Federation.
M E BorodinaHertsen Moscow Oncology Research Institute, Moscow, 125284 Russian Federation.
V I ChernovTomsk Cancer Research Institute, Tomsk, 634009 Russian Federation.
V M TolmachevUppsala University, Uppsala, 75185 Sweden.
S M DeyevNational Research Tomsk Polytechnic University, Tomsk, 634050 Russian Federation.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anatomic visualization and molecular typing of metastatic regional lymph nodes in breast cancer patients are a serious clinical challenge in modern oncology. According to the results of previous studies, [99mTc]Tc-(HE)3-G3 has proven to be a promising diagnostic agent in differentiating the HER2/neu receptor status in primary breast tumors (

Indexed as

breast cancerDARPinG3HER2/neulymph node metastasisradionuclide diagnostics

Identifiers

PMID39188262
PMCPMC11345088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.